Hemedex
Medical Devices, 564 Main St, Waltham, Massachusetts, 88310, United States, 11-50 Employees
Phone Number: +16*********
Who is HEMEDEX
HEMEDEX INC. was founded in 2000 to commercialize a proprietary platform technology conceived at the Massachusetts Institute of Technology (MIT) to quantify tissue perfusion (i.e., blood ...
Read More
-
Headquarters: 564 Main St, Waltham, Massachusetts, 88310, United States
-
Date Founded: 2000
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
-
CEO:
H Bowman
Email
Phone
Industry: Medical Devices
SIC Code: 7379
|
NAICS Code: 541519 |
Show More
HEMEDEX Org Chart and Mapping
Similar Companies to HEMEDEX
Boston Scientific
-
10001+
-
$ 1 Billion and Over
NanoHive Medical
-
11-50
-
$ 5 Million to 10 Million
Ottalaus Health
-
11-50
-
$ Under 1 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding HEMEDEX
Answer: HEMEDEX's headquarters are located at 564 Main St, Waltham, Massachusetts, 88310, United States
Answer: HEMEDEX's phone number is +16*********
Answer: HEMEDEX's official website is https://hemedex.com
Answer: HEMEDEX's revenue is $1 Million to $5 Million
Answer: HEMEDEX's SIC: 7379
Answer: HEMEDEX's NAICS: 541519
Answer: HEMEDEX has 11-50 employees
Answer: HEMEDEX is in Medical Devices
Answer: HEMEDEX top competitors include: Boston Scientific , NanoHive Medical , Ottalaus Health
Answer: HEMEDEX contact info: Phone number: +16********* Website: https://hemedex.com
Answer: HEMEDEX INC. was founded in 2000 to commercialize a proprietary platform technology conceived at the Massachusetts Institute of Technology (MIT) to quantify tissue perfusion (i.e., blood flow at the capillary level). This technology addresses the need for real-time, prognostic data in complex medical and surgical procedures. These complex procedures often involve compromised vasculature, delayed ischemia, or other serious pathophysiology, resulting in high rates of morbidity, delayed recuperation, poor patient outcome and higher overall costs. HEMEDEX's patented technology can provide an early warning of impending tissue ischemia, help target appropriate therapies, and rapidly assess the effect of interventions on cerebral blood flow (CBF), thus providing clinicians with a powerful tool to enhance patient care. HEMEDEX is ISO 13485:2012 certified.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month